4.6 Review

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review

Journal

CANCERS
Volume 14, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/cancers14040920

Keywords

breast cancer; endocrine therapy; cognitive dysfunction

Categories

Funding

  1. National Health Medical Research Council Investigator Grant [APP1176221]
  2. National Breast Cancer Foundation Endowed Chair [EC17-02]
  3. Love Your Sister

Ask authors/readers for more resources

This review focuses on cognitive dysfunction associated with endocrine therapy for breast cancer, aiming to provide evidence-based management strategies. Endocrine therapy is a crucial treatment for breast cancer patients, but its side effects can negatively impact quality of life, treatment adherence, and outcomes. Cognitive adverse effects are common but often underreported and challenging to manage. Therefore, proactive management by a multidisciplinary team is essential to promote adherence and improve patients' quality of life.
Simple Summary Many persons diagnosed with breast cancer are treated with endocrine therapy and will experience the side effects of endocrine therapy. Cognitive adverse effects of endocrine therapy are increasingly being recognised, and can significantly affect quality of life, adherence and treatment outcome. This review aims to discuss the nature of cognitive dysfunction associated with endocrine therapy, the mechanisms underpinning its development, and evidence-based management strategies. Endocrine therapy forms the backbone of systemic therapy for the majority of persons with early and late-stage breast cancer. However, the side effects can negatively affect quality of life, and impact treatment adherence and overall oncological outcomes. Adverse effects on cognition are common, underreported and challenging to manage. We aim to describe the nature, incidence, risk factors and underlying mechanisms of endocrine therapy-induced cognitive dysfunction. We conducted a comprehensive literature review of the studies reporting on cognitive dysfunction associated with endocrine therapies for breast cancer. We also summarise prevention and treatment strategies, and ongoing research. Given that patients are taking endocrine therapies for longer durations than ever before, it is essential that these side effects are managed pro-actively within a multi-disciplinary team in order to promote adherence to endocrine therapy and improve patients' quality of life.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available